Royalty Pharma Plc share price logo

Royalty Pharma Plc Share Price

NASDAQ: RPRX

Large Cap

$36.37

-0.33

(-0.90%)

as on

Royalty Pharma Plc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $36.21
    $36.82
    downward going graph

    0.44%

    Downside

    1.24%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $24.05
    $38
    downward going graph

    33.87%

    Downside

    4.48%

    Upside

    downward going graph

Royalty Pharma Plc share price movements today

Previous Close
$36.70
Open
$36.59
Volume
2.7M
Day's Low - High
$36.21 - $36.82
52 Week Low - High
$24.05 - $38

Royalty Pharma Plc Historical Returns

1 Month Return
+ 0.66 %
3 Month Return
+ 5.34 %
1 Year Return
+ 32.4 %
3 Year Return
-13.87 %
5 Year Return
-4.82 %

Royalty Pharma Plc Stock Fundamentals & Key Indicators

Check Royalty Pharma Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$21.2B

EPS (TTM)

4.4801

Dividend Yield

2.79%

Quarterly Earnings Growth YOY

-0.69%

PE Ratio (TTM)

15.88

Industry PE ratio

16.65525641025641

P/B Ratio

15.8777

PEG Ratio

2.755

EBITDA

1.5B

Revenue (TTM)

2.3B

Profit Margin

44.28%

Return On Equity TTM

17.29%

Royalty Pharma Plc Stock Valuation

Track how Royalty Pharma Plc P/E has moved over time to understand its valuation trends.

Royalty Pharma Plc in the last 5 years

  • Overview

  • Trends

Lowest (5.79x)

December 31, 2023

Today (15.88x)

September 13, 2025

Industry (16.66x)

September 13, 2025

Highest (18.03x)

March 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 15.88x

Royalty Pharma Plc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Royalty Pharma Plc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$21.2B-4.82%15.8844.28%
BUY$61.1B280.5%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.2B54.04%28.0831.86%
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Royalty Pharma Plc Stock including INR - Dollar returns

The Royalty Pharma Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Royalty Pharma Plc investment value today

Current value as on today

₹1,36,344

Returns

₹36,344

(+36.34%)

Returns from Royalty Pharma Plc Stock

₹31,205 (+31.2%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Royalty Pharma Plc Stock

Based on 14 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Royalty Pharma Plc. Average target price of $44.86

Royalty Pharma Plc Share Price Target

Get share price movements and forecasts by analysts on Royalty Pharma Plc.

What analysts predicted

18.93%UPSIDE

Target Price

$44.86

Current Price

$36.37

Analyzed by

14 Analysts

Target

$44.86

Royalty Pharma Plc target price $44.86, a slight upside of 18.93% compared to current price of $36.37. According to 14 analysts rating.

Royalty Pharma Plc Stock's Interest Amongst Investors

Search interest for Royalty Pharma Plc Stock has increased by 34% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:34% versus previous 30 day period

Royalty Pharma Plc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
683
538
536
596
567
537
564
593
568
578
Gross Profit
565
296
259
596
567
537
564
593
568
578
Operating Income
478
248
151
612
-73
269
735
361
534
209
EBITDA
556
398
168
764
39
243
872
400
498
159
Interest Expense
46
46
46
47
44
49
66
65
65
68
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
509
351
122
717
-4
194
806
334
433
90
Income Tax Expense
168
123
49
223
-9
92
262
126
-
60
Net Income
340
227
72
494
4
102
543
208
238
30
Net Profit Margin
49.82%
42.29%
13.45%
82.93%
0.84%
18.99%
96.33%
35.07%
41.94%
5.21%

Royalty Pharma Plc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
1,652
1,877
1,597
1,794
1,814
2,122
2,289
2,237
2,354
2,263
Gross Profit
1,652
1,877
1,564
1,658
794
2,033
2,289
2,237
2,354
2,263
Operating Income
794
722
939
1,364
2,623
1,595
1,430
307
1,492
1,292
EBITDA
862
1,069
1,623
1,831
2,753
1,882
1,430
423
1,887
1,556
Interest Expense
224
238
247
279
268
157
166
187
187
225
Depreciation
-
-
33
33
23
23
22
5
-
-
Income Before Tax
758
761
1,343
1,517
2,461
1,701
1,241
230
1,700
1,330
Income Tax Expense
177
195
542
433
349
1,147
762
187
565
472
Net Income
581
565
1,210
1,377
2,348
975
619
42
1,134
858
Net Profit Margin
35.19%
30.14%
75.72%
76.76%
129.45%
45.94%
27.07%
1.91%
48.20%
37.95%

Royalty Pharma Plc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
351
122
717
-4
194
806
334
433
30
Operating Cash Flow
607
573
772
664
658
703
742
596
426
Investing Cash Flow
-63
-450
-1,000
-86
-893
-1,192
-505
503
-370
Financing Cash Flow
-346
-1,359
-231
-211
1,156
-325
-257
-941
-512
Change in Cash
197
-1,236
-459
365
921
-814
-21
158
-455

Royalty Pharma Plc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-17
1,343
1,517
2,461
1,701
1,241
230
1,700
1,330
Operating Cash Flow
-15
1,418
1,618
1,667
2,034
2,017
2,143
2,987
2,768
Investing Cash Flow
-
-1,587
303
-2,153
-2,759
-1,870
-1,029
-2,072
-2,678
Financing Cash Flow
2
-123
-1,379
-1,191
1,487
385
-944
-2,148
361
Change in Cash
-12
-292
542
-1,640
763
532
169
-1,233
452

Global Institutional Holdings in Royalty Pharma Plc

Funds
Holdings
Morgan Stanley - Brokerage Accounts
9.49%
FMR Inc
9.12%
Vanguard Group Inc
8.48%
BlackRock Inc
5.68%
Baillie Gifford & Co Limited.
4.17%

Royalty Pharma Plc News & Key Events

  • img

    Today's Timeline - 03 September

    Wed, 12:35 PM

    -

    Royalty Pharma prices $2.0 billion of senior unsecured notes for general corporate purposes, closing expected on September 16, 2025.

    Wed, 04:59 PM

    -

    Morgan Stanley maintains Buy rating on RPRX, citing strategic moves and growth prospects, including a $75 million funding agreement.

Insights on Royalty Pharma Plc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 568.24M → 578.66M (in $), with an average increase of 1.8% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, RPRX stock has moved up by 31.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.7% return, outperforming this stock by 138.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 44.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 238.34M → 30.17M (in $), with an average decrease of 87.3% per quarter

About Royalty Pharma Plc

royalty pharma is the industry leader in acquiring revenue-producing intellectual property – principally royalty interests in marketed and late stage biopharmaceutical products with $13 billion in assets. since inception in 1996, royalty pharma and its predecessors have invested approximately $5.8 billion to assemble a leading portfolio of royalty interests in pharmaceutical and biopharmaceutical products. royalty pharma’s strategy has been to acquire royalty interests in leading pharmaceutical and biotechnology products and hold these interests as part of a portfolio, seeking to diversify its revenue base across product and therapeutic classes. royalty pharma captures many of the strong and predictable aspects of the pharmaceutical industy while limiting the typical risks of biopharmaceutical companies. royalty pharma currently owns a diversified portfolio of royalty interests in several high- quality blockbuster biopharmaceutical products, including abbott’s humira®, j&j/merck’s remi
OrganisationRoyalty Pharma Plc
Headquarters110 East 59th Street, New York, NY, United States, 10022
IndustryHealth Technology
CEOMr. Pablo Gerardo Legorreta
E-voting on sharesClick here to vote

Key Management of Royalty Pharma Plc

Name

Title

Dr. Marshall Jonathan Urist M.D., Ph.D.

Executive Vice President of Research & Investments

Mr. Ashwin Pai M.D.

Executive Vice President of Investments

Dr. James Folmar Reddoch Ph.D.

Executive VP of Investments & Chief Scientific Officer

Mr. Pablo Gerardo Legorreta

Founder, Chairman of the Board & CEO

Mr. Terrance P. Coyne

Executive VP & CFO

Mr. Arthur Richard McGivern J.D.

Executive Vice President of Investments & General Counsel

Mr. Eric Cornelius Schneider

Senior VP & Chief Technology Officer

Mr. George Grofik C.F.A., CPA

Senior VP and Head of Investor Relations & Communications

Mr. George Wingate Lloyd

Executive VP of Investments & Chief Legal Officer

Mr. Christopher Hite

Vice Chairman & Executive VP

FAQs

What is Royalty Pharma Plc share price today?

Royalty Pharma Plc share price today is $36.37 as on at the close of the market. Royalty Pharma Plc share today touched a day high of $36.82 and a low of $36.21.

What is the 52 week high and 52 week low for Royalty Pharma Plc share?

Royalty Pharma Plc share touched a 52 week high of $38 on and a 52 week low of $24.05 on . Royalty Pharma Plc stock price today i.e. is closed at $36.37,which is 4.29% down from its 52 week high and 51.23% up from its 52 week low.

What is Royalty Pharma Plc's market capitalisation today?

Royalty Pharma Plc market capitalisation is $0.02T as on .

How to invest in Royalty Pharma Plc Stock (RPRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Royalty Pharma Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Royalty Pharma Plc Shares that will get you 0.0412 shares as per Royalty Pharma Plc share price of $36.37 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Royalty Pharma Plc Stock (RPRX) from India?

Indian investors can start investing in Royalty Pharma Plc (RPRX) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Royalty Pharma Plc stock (as per the Rupee-Dollar exchange rate as on ). Based on Royalty Pharma Plc share’s latest price of $36.37 as on September 13, 2025 at 1:29 am IST, you will get 0.2750 shares of Royalty Pharma Plc. Learn more about fractional shares .

What are the returns that Royalty Pharma Plc has given to Indian investors in the last 5 years?

Royalty Pharma Plc stock has given -4.82% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?